Bonner Michael 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed May 18, 2018
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2018-05-17$6.12/sh+400$2,448→ 18,054 total
4 · CUMBERLAND PHARMACEUTICALS INC · Filed May 18, 2018
Common Stock